384 related articles for article (PubMed ID: 34694158)
1. Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome.
Sánchez-López A; Espinós-Estévez C; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; Fanjul V; Riquelme-Borja R; Hamczyk MR; Macías Á; Del Campo L; Camafeita E; Vázquez J; Barkaway A; Rolas L; Nourshargh S; Dorado B; Benedicto I; Andrés V
Circulation; 2021 Nov; 144(22):1777-1794. PubMed ID: 34694158
[TBL] [Abstract][Full Text] [Related]
2. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
[TBL] [Abstract][Full Text] [Related]
3. Exacerbated atherosclerosis in progeria is prevented by progerin elimination in vascular smooth muscle cells but not endothelial cells.
Benedicto I; Carmona RM; Barettino A; Espinós-Estévez C; Gonzalo P; Nevado RM; de la Fuente-Pérez M; Andrés-Manzano MJ; González-Gómez C; Rolas L; Dorado B; Nourshargh S; Hamczyk MR; Andrés V
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2400752121. PubMed ID: 38648484
[TBL] [Abstract][Full Text] [Related]
4. Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models.
Benedicto I; Dorado B; Andrés V
Cells; 2021 May; 10(5):. PubMed ID: 34064612
[TBL] [Abstract][Full Text] [Related]
5. Vascular Smooth Muscle Cell-Specific Progerin Expression Provokes Contractile Impairment in a Mouse Model of Hutchinson-Gilford Progeria Syndrome that Is Ameliorated by Nitrite Treatment.
Del Campo L; Sánchez-López A; González-Gómez C; Andrés-Manzano MJ; Dorado B; Andrés V
Cells; 2020 Mar; 9(3):. PubMed ID: 32182706
[TBL] [Abstract][Full Text] [Related]
6. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V
Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466
[TBL] [Abstract][Full Text] [Related]
7. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
[TBL] [Abstract][Full Text] [Related]
8. Vascular smooth muscle cell loss underpins the accelerated atherosclerosis in Hutchinson-Gilford progeria syndrome.
Hamczyk MR; Andrés V
Nucleus; 2019 Dec; 10(1):28-34. PubMed ID: 30900948
[TBL] [Abstract][Full Text] [Related]
9. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome.
Varga R; Eriksson M; Erdos MR; Olive M; Harten I; Kolodgie F; Capell BC; Cheng J; Faddah D; Perkins S; Avallone H; San H; Qu X; Ganesh S; Gordon LB; Virmani R; Wight TN; Nabel EG; Collins FS
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3250-5. PubMed ID: 16492728
[TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle cell-specific progerin expression in a mouse model of Hutchinson-Gilford progeria syndrome promotes arterial stiffness: Therapeutic effect of dietary nitrite.
Del Campo L; Sánchez-López A; Salaices M; von Kleeck RA; Expósito E; González-Gómez C; Cussó L; Guzmán-Martínez G; Ruiz-Cabello J; Desco M; Assoian RK; Briones AM; Andrés V
Aging Cell; 2019 Jun; 18(3):e12936. PubMed ID: 30884114
[TBL] [Abstract][Full Text] [Related]
11. Nuclear membrane ruptures underlie the vascular pathology in a mouse model of Hutchinson-Gilford progeria syndrome.
Kim PH; Chen NY; Heizer PJ; Tu Y; Weston TA; Fong JL; Gill NK; Rowat AC; Young SG; Fong LG
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34423791
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome.
Macías Á; Díaz-Larrosa JJ; Blanco Y; Fanjul V; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; da Rocha AM; Ponce-Balbuena D; Allan A; Filgueiras-Rama D; Jalife J; Andrés V
Cardiovasc Res; 2022 Jan; 118(2):503-516. PubMed ID: 33624748
[TBL] [Abstract][Full Text] [Related]
13. Progerin impairs vascular smooth muscle cell growth via the DNA damage response pathway.
Kinoshita D; Nagasawa A; Shimizu I; Ito TK; Yoshida Y; Tsuchida M; Iwama A; Hayano T; Minamino T
Oncotarget; 2017 May; 8(21):34045-34056. PubMed ID: 28423660
[TBL] [Abstract][Full Text] [Related]
14. Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells.
Hamczyk MR; Villa-Bellosta R; Quesada V; Gonzalo P; Vidak S; Nevado RM; Andrés-Manzano MJ; Misteli T; López-Otín C; Andrés V
EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30862662
[TBL] [Abstract][Full Text] [Related]
15. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
16. In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice.
Koblan LW; Erdos MR; Wilson C; Cabral WA; Levy JM; Xiong ZM; Tavarez UL; Davison LM; Gete YG; Mao X; Newby GA; Doherty SP; Narisu N; Sheng Q; Krilow C; Lin CY; Gordon LB; Cao K; Collins FS; Brown JD; Liu DR
Nature; 2021 Jan; 589(7843):608-614. PubMed ID: 33408413
[TBL] [Abstract][Full Text] [Related]
17. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.
Lee SJ; Jung YS; Yoon MH; Kang SM; Oh AY; Lee JH; Jun SY; Woo TG; Chun HY; Kim SK; Chung KJ; Lee HY; Lee K; Jin G; Na MK; Ha NC; Bárcena C; Freije JM; López-Otín C; Song GY; Park BJ
J Clin Invest; 2016 Oct; 126(10):3879-3893. PubMed ID: 27617860
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry.
Camafeita E; Jorge I; Rivera-Torres J; Andrés V; Vázquez J
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233036
[TBL] [Abstract][Full Text] [Related]
19. Disrupting the LINC complex in smooth muscle cells reduces aortic disease in a mouse model of Hutchinson-Gilford progeria syndrome.
Kim PH; Luu J; Heizer P; Tu Y; Weston TA; Chen N; Lim C; Li RL; Lin PY; Dunn JCY; Hodzic D; Young SG; Fong LG
Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257952
[TBL] [Abstract][Full Text] [Related]
20. Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome.
Beyret E; Liao HK; Yamamoto M; Hernandez-Benitez R; Fu Y; Erikson G; Reddy P; Izpisua Belmonte JC
Nat Med; 2019 Mar; 25(3):419-422. PubMed ID: 30778240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
